Subscribe To
Amazon pharmacy launches automatic coupons for $35 insulin
Amazon.com Inc. AMZN said Tuesday that its Amazon Pharmacy unit is introducing automatic coupons on insulin, continuous ...
August 15, 2023, 9:07 am
Nemaura medical secures $6.5m in non-dilutive funding
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializin...
August 11, 2023, 8:05 pm
glucose monitor maker dexcom in buy zone after gapping higher
glucose-monitor maker DexCom Inc. NASDAQ: DXCM was among the top three gainers within the healthcare se...
July 31, 2023, 9:10 am
Dexcom (dxcm) q2 earnings beat estimates, volumes remain strong
DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous ...
July 28, 2023, 10:15 am
Dexcom lifts revenue forecast on demand for glucose-monitoring devices
Medical device maker Dexcom Inc on Thursday raised its annual revenue forecast after strong demand for its continuous ...
July 27, 2023, 5:02 pm
Avricore health to enhance diabetes care through integration of healthtab with contour blood glucose meters
Avricore Health (TSX-V:AVCR, OTC:AVCRF) announced that it has partnered with Ascensia Diabetes Care to integrate its blood ...
July 19, 2023, 8:58 am
2 growth stocks that could double in 5 years
DexCom is making continuous glucose monitoring technology more widespread. Etsy is highly successful in...
July 7, 2023, 10:15 am
Nutritional beverage company glucose health pulls planned ipo
glucose Health Inc., a provider of soluble fiber infused nutritional beverages, pulled its planned init...
June 28, 2023, 2:15 pm
Terns pharmaceuticals highlights new preclinical data for tern-601 program in obesity at the ada’s 83rd annual scientific session and upcoming events
TERN-601 significantly improved glucose tolerance, suppressed food intake and slowed gastric emptying i...
June 26, 2023, 8:05 pm
Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model
Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...
June 24, 2023, 12:00 pm
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Biomea fusion presents positive clinical data from the initial cohorts of the ongoing phase ii study (covalent-111) of bmf-219 in patients with type 2 diabetes mellitus at the american diabetes associ
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an increase of C-peptide and an improvement of HOMA-B,...
June 24, 2023, 1:54 am
Carmot therapeutics highlights clinical data from its pipeline of treatments for obesity and diabetes at the 83rd american diabetes association scientific sessions
– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic control with a favorable tolerability profile over a...
June 24, 2023, 1:30 am
Dexcom clears base, wall street eyes double-digit earnings growth
You generally associate Super Bowl commercials with products made by PepsiCo Inc. NYSE: PEP or the Coca-Cola Co. NYSE: KO, but earlier this year,
June 21, 2023, 10:26 am
Senseonics shares jump 6.7% on new insurance coverage for continuous glucose monitor
Shares of medical technology company Senseonics Holdings Inc. SENS, -0.52% gained 6.7% premarket on Friday after the company announced that UnitedHeal...
June 2, 2023, 8:34 am